Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pathophysiological role of oxidative stress in systolic and diastolic heart failure and its therapeutic implications
Thomas Münzel, Tommaso Gori, John F. Keaney, et al.
European Heart Journal (2015) Vol. 36, Iss. 38, pp. 2555-2564
Open Access | Times Cited: 342

Showing 26-50 of 342 citing articles:

Expanding the Frontiers of Guardian Antioxidant Selenoproteins in Cardiovascular Pathophysiology
Tommaso Angelone, Carmine Rocca, Vincenzo Lionetti, et al.
Antioxidants and Redox Signaling (2024) Vol. 40, Iss. 7-9, pp. 369-432
Closed Access | Times Cited: 18
<p>Would Colloidal Gold Nanocarriers Present An Effective Diagnosis Or Treatment For Ischemic Stroke?</p>
Hamed Amani, Ebrahim Mostafavi, Mahmoud Reza Alebouyeh, et al.
International Journal of Nanomedicine (2019) Vol. Volume 14, pp. 8013-8031
Open Access | Times Cited: 138
Redox regulation of cardiovascular inflammation – Immunomodulatory function of mitochondrial and Nox-derived reactive oxygen and nitrogen species
Philip Wenzel, Sabine Kossmann, Thomas Münzel, et al.
Free Radical Biology and Medicine (2017) Vol. 109, pp. 48-60
Closed Access | Times Cited: 135
Antineoplastic Drug-Induced Cardiotoxicity: A Redox Perspective
Gilda Varricchi, Pietro Ameri, Christian Cadeddu Dessalvi, et al.
Frontiers in Physiology (2018) Vol. 9
Open Access | Times Cited: 135
Revisiting pharmacology of oxidative stress and endothelial dysfunction in cardiovascular disease: Evidence for redox-based therapies
Andreas Daiber, Stefan Chłopicki
Free Radical Biology and Medicine (2020) Vol. 157, pp. 15-37
Open Access | Times Cited: 135
Lifestyle Modifications for Preventing and Treating Heart Failure
Monica Aggarwal, Biykem Bozkurt, Gurusher Panjrath, et al.
Journal of the American College of Cardiology (2018) Vol. 72, Iss. 19, pp. 2391-2405
Closed Access | Times Cited: 127
Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients
Yong‐ho Lee, Kwang Joon Kim, Myungeun Yoo, et al.
Journal of Hepatology (2017) Vol. 68, Iss. 4, pp. 764-772
Closed Access | Times Cited: 110
Empagliflozin, an SGLT2 Inhibitor, Reduced the Mortality Rate after Acute Myocardial Infarction with Modification of Cardiac Metabolomes and Antioxidants in Diabetic Rats
H Oshima, Takayuki Miki, Atsushi Kuno, et al.
Journal of Pharmacology and Experimental Therapeutics (2018) Vol. 368, Iss. 3, pp. 524-534
Open Access | Times Cited: 110
Cardiac Pathophysiology and the Future of Cardiac Therapies in Duchenne Muscular Dystrophy
Tatyana A. Meyers, DeWayne Townsend
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 17, pp. 4098-4098
Open Access | Times Cited: 105
Oxidative Stress, Kinase Activity and Inflammatory Implications in Right Ventricular Hypertrophy and Heart Failure under Hypobaric Hypoxia
Eduardo Pena, Julio Brito, Samia El Alam, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 6421-6421
Open Access | Times Cited: 102
The pathophysiology of myocardial infarction-induced heart failure
Daniele Gabriel‐Costa
Pathophysiology (2018) Vol. 25, Iss. 4, pp. 277-284
Closed Access | Times Cited: 101
Dietary Patterns and Incident Heart Failure in U.S. Adults Without Known Coronary Disease
Kyla M. Lara, Emily B. Levitan, Orlando M. Gutiérrez, et al.
Journal of the American College of Cardiology (2019) Vol. 73, Iss. 16, pp. 2036-2045
Open Access | Times Cited: 96
Novel sGC Stimulators and sGC Activators for the Treatment of Heart Failure
Stefanie Breitenstein, Lothar Roessig, Peter Sandner, et al.
Handbook of experimental pharmacology (2016), pp. 225-247
Closed Access | Times Cited: 92
The Ubiquitin-Like SUMO System and Heart Function
Luca Mendler, Thomas Braun, Stefan Müller
Circulation Research (2016) Vol. 118, Iss. 1, pp. 132-144
Open Access | Times Cited: 90
Oxidative stress and atrial fibrillation: an update
Panagiotis Korantzopoulos, Κonstantinos P. Letsas, Nikolaos Fragakis, et al.
Free Radical Research (2018) Vol. 52, Iss. 11-12, pp. 1199-1209
Closed Access | Times Cited: 90
Luteolin Exerts Neuroprotection via Modulation of the p62/Keap1/Nrf2 Pathway in Intracerebral Hemorrhage
Xin Tan, Yi Yang, Jianguo Xu, et al.
Frontiers in Pharmacology (2020) Vol. 10
Open Access | Times Cited: 86
RAPID-CPU: a prospective study on implementation of the ESC 0/1-hour algorithm and safety of discharge after rule-out of myocardial infarction
Kiril M. Stoyanov, Hauke Hund, Moritz Biener, et al.
European Heart Journal Acute Cardiovascular Care (2019) Vol. 9, Iss. 1, pp. 39-51
Open Access | Times Cited: 85
Emergence of SGLT2 Inhibitors as Powerful Antioxidants in Human Diseases
Kai‐Fan Tsai, Yung‐Lung Chen, Terry Ting-Yu Chiou, et al.
Antioxidants (2021) Vol. 10, Iss. 8, pp. 1166-1166
Open Access | Times Cited: 79
Herceptin induces ferroptosis and mitochondrial dysfunction in H9c2 cells
Lei Sun, Hua Wang, Shanshan Yu, et al.
International Journal of Molecular Medicine (2021) Vol. 49, Iss. 2
Open Access | Times Cited: 76
Inhibition of aquaporin-1 prevents myocardial remodeling by blocking the transmembrane transport of hydrogen peroxide
Virginie Montiel, Ramona Bella, Lauriane Y. M. Michel, et al.
Science Translational Medicine (2020) Vol. 12, Iss. 564
Open Access | Times Cited: 72
Role of oxidative stress in calcific aortic valve disease and its therapeutic implications
Harry Z.E. Greenberg, Guoan Zhao, Ajay M. Shah, et al.
Cardiovascular Research (2021) Vol. 118, Iss. 6, pp. 1433-1451
Open Access | Times Cited: 59
Reactive Oxygen Species Induced Pathways in Heart Failure Pathogenesis and Potential Therapeutic Strategies
Aušra Mongirdienė, L Skrodenis, Leila Varoneckaitė, et al.
Biomedicines (2022) Vol. 10, Iss. 3, pp. 602-602
Open Access | Times Cited: 44
Adverse outcome pathway of fine particulate matter leading to increased cardiovascular morbidity and mortality: An integrated perspective from toxicology and epidemiology
Yang Yu, Qinglin Sun, Tianyu Li, et al.
Journal of Hazardous Materials (2022) Vol. 430, pp. 128368-128368
Closed Access | Times Cited: 43
A Self‐Sustaining Antioxidant Strategy for Effective Treatment of Myocardial Infarction
Quan Sun, Hongqin Ma, Jiaxiong Zhang, et al.
Advanced Science (2022) Vol. 10, Iss. 5
Open Access | Times Cited: 43
Sirtuin 2 deficiency aggravates ageing-induced vascular remodelling in humans and mice
Yang Zhang, Xiaoman Wang, Xun-Kai Li, et al.
European Heart Journal (2023) Vol. 44, Iss. 29, pp. 2746-2759
Open Access | Times Cited: 33

Scroll to top